Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Bicomponent Capsules for Bacterial Vaginosis
NCT07418918Phase 2Completed
- Sponsor
- Longchuangji Pharmaceutical
- Start
- Jan 2023
- Primary completion
- Sep 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of live double combined lactobacillus in bacterial vaginosis (BV), sponsored by Longchuangji Pharmaceutical. Started Jan 2023; status: completed.
02
Drugs
live double combined lactobacillus
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07418918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07418918.